Skip to content
ClinCalc Pro
Menu
Antiplatelet

Aspirin

Brand names: Aspirin, Nu-Seals

Aspirin (acetylsalicylic acid) is an antiplatelet agent used in the acute treatment and secondary prevention of ischaemic stroke and transient ischaemic attack.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It irreversibly acetylates platelet cyclo-oxygenase-1, blocking thromboxane A2 production and thereby inhibiting platelet aggregation for the lifetime of the platelet.

Prescribing in practice

  • Haemorrhagic stroke must be excluded by imaging before starting, as aspirin increases bleeding risk; the main hazards are gastrointestinal and intracranial haemorrhage.
  • Use with caution in active peptic ulceration, bleeding disorders and uncontrolled hypertension, and consider gastroprotection in those at risk.
  • It is started promptly after confirmed ischaemic stroke and may be followed by longer-term antiplatelet therapy.

Monitoring

No routine laboratory monitoring is required, but watch for signs of gastrointestinal or other bleeding.

Counselling the patient

  • Take with or after food to reduce stomach irritation.
  • Report black stools, vomiting blood or unusual bruising.
  • Tell clinicians you take aspirin before any surgery or dental work.

Evidence & guidelines

Early aspirin after acute ischaemic stroke is supported by the CAST and IST trials and recommended by NICE.

Reference: NICE NG128; NICE NG185; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.